Average Insider

Where insiders trade, we follow

ROTE WILLIAM E.

Chief Research Officer
CIK: 1698262

All Transactions

DateCompanyTypeSharesPriceValueActions
Sep 16, 2026Travere Therapeutics, Inc. (TVTX)M57,500$0.00$0.00View Details Filing
Sep 16, 2026Travere Therapeutics, Inc. (TVTX)M350$0.00$0.00View Details Filing
Sep 16, 2026Travere Therapeutics, Inc. (TVTX)M350$17.96$6,286.00View Details Filing
Sep 16, 2026Travere Therapeutics, Inc. (TVTX)M55,000$15.46$850,300.00View Details Filing
Sep 16, 2026Travere Therapeutics, Inc. (TVTX)M57,500$26.88$1,545,600.00View Details Filing
Sep 16, 2026Travere Therapeutics, Inc. (TVTX)S65,104$63.12$4,109,397.03View Details Filing
Sep 16, 2026Travere Therapeutics, Inc. (TVTX)S47,746$63.61$3,037,247.20View Details Filing
Sep 16, 2026Travere Therapeutics, Inc. (TVTX)M55,000$0.00$0.00View Details Filing
Sep 15, 2026Travere Therapeutics, Inc. (TVTX)M39,000$25.25$984,750.00View Details Filing
Sep 15, 2026Travere Therapeutics, Inc. (TVTX)M39,650$17.96$712,114.00View Details Filing
Sep 15, 2026Travere Therapeutics, Inc. (TVTX)S63,907$61.99$3,961,850.56View Details Filing
Sep 15, 2026Travere Therapeutics, Inc. (TVTX)S29,021$62.66$1,818,316.56View Details Filing
Sep 15, 2026Travere Therapeutics, Inc. (TVTX)M39,650$0.00$0.00View Details Filing
Sep 15, 2026Travere Therapeutics, Inc. (TVTX)S3,000$63.65$190,952.40View Details Filing
Sep 15, 2026Travere Therapeutics, Inc. (TVTX)S270$65.31$17,633.70View Details Filing
Sep 15, 2026Travere Therapeutics, Inc. (TVTX)M39,000$0.00$0.00View Details Filing
12 more transactions available โ€” create a free account to see 12 months of history
Version: v26.9.1